(Q24236500)

non-alcoholic fatty liver

inferred from title

1 reference

1 reference

Lijun Peng

1

0 references

Jiyao Wang

series ordinal

2

0 references

Feng Li

series ordinal

3

0 references

publication date

15 June 2011

0 references

published in

Cochrane Database of Systematic Reviews

0 references

cites work

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

A pilot study of orlistat treatment in obese, non-alcoholic steatohepatitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Effects of therapeutic lifestyle program on ultrasound-diagnosed nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

The effects of aerobic exercise on metabolic risk, insulin sensitivity and intrahepatic lipid in healthy older people from the Hertfordshire Cohort Study: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Efficacy and safety of very-low-calorie diet in Taiwanese: a multicenter randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Therapeutic effects of restricted diet and exercise in obese patients with fatty liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Effects of weight loss surgeries on liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Management of nonalcoholic fatty liver disease: weight control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Bariatric surgery worldwide 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Bariatric surgery for non-alcoholic steatohepatitis in obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

The impact of bariatric surgery on nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Surgical options for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Surgical treatment for obesity and its impact on non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Benefits of lifestyle modification in NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

The epidemiology of nonalcoholic fatty liver disease: a global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Nonalcoholic steatohepatitis: a study of 49 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Hepatic Complications of Jejunoileal Bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Weight reduction for non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Effects of weight loss on nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Nonalcoholic Steatohepatitis in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

The metabolically obese, normal-weight individual revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Chronological development of elevated aminotransferases in a nonalcoholic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Visceral fat: a key mediator of steatohepatitis in metabolic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Is weight reduction an effective therapy for nonalcoholic fatty liver? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

Independent effects of physical activity in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

7 January 2021

A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

7 January 2021

Orlistat reverse fatty infiltration and improves hepatic fibrosis in obese patients with nonalcoholic steatohepatitis (NASH)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

7 January 2021

A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

7 January 2021

Long-term consequences after jejunoileal bypass for morbid obesity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

7 January 2021

Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

7 January 2021

Prevalence of and risk factors for hepatic steatosis in Northern Italy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003619.PUB3

7 January 2021

10.1002/14651858.CD003619.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4986171

OpenCitations bibliographic resource ID

4986171

1 reference